Share

April 09, 2019; 92 (15 Supplement) May 5, 2019

The Impact of Fremanezumab on Medication Overuse in Patients With Chronic Migraine (P1.10-026)

Stephen Silberstein, Sait Ashina, Zaza Katsarava, Kristen Bibeau, Michael Seminerio, Danielle Harlow, Joshua Cohen
First published April 16, 2019,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 92 no. 15 Supplement P1.10-026
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 16, 2019.
Copyright & Usage: 
© 2019

Author Disclosures

    1. Stephen Silberstein, MD1,
    2. Sait Ashina, MD2,
    3. Zaza Katsarava, MD3,
    4. Kristen Bibeau, PhD, MSPH4,
    5. Michael Seminerio, PhD, MBA4,
    6. Danielle Harlow, PhD4 and
    7. Joshua Cohen, MD, MPH, FAHS4
  1. Stephen Silberstein, MD1,
  2. Sait Ashina, MD2,
  3. Zaza Katsarava, MD3,
  4. Kristen Bibeau, PhD, MSPH4,
  5. Michael Seminerio, PhD, MBA4,
  6. Danielle Harlow, PhD4 and
  7. Joshua Cohen, MD, MPH, FAHS4
  1. 1Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA Philadelphia PA United States
  2. 2Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA Brookline MA United States
  3. 3University of Essen, Unna, Germany Essen Germany
  4. 4Teva Pharmaceuticals, Frazer, Pennsylvania, USA Frazer PA United States

Article usage

Article usage: April 2019 to January 2023

AbstractFullPdfSource
Apr 2019600Highwire
May 20192900Highwire
Jun 20192100Highwire
Jul 2019700Highwire
Aug 2019900Highwire
Sep 20191300Highwire
Oct 20191900Highwire
Nov 20191200Highwire
Dec 20191100Highwire
Jan 2020600Highwire
Feb 20201100Highwire
Mar 2020200Highwire
Apr 20201300Highwire
May 20201000Highwire
Jun 20202900Highwire
Jul 20201600Highwire
Aug 20201300Highwire
Sep 20203600Highwire
Oct 20201500Highwire
Nov 2020400Highwire
Dec 2020700Highwire
Jan 2021300Highwire
Feb 2021500Highwire
Mar 20211700Highwire
Apr 20211000Highwire
May 20211100Highwire
Jun 20211100Highwire
Jul 2021300Highwire
Aug 20211000Highwire
Sep 2021900Highwire
Oct 2021800Highwire
Nov 2021600Highwire
Dec 2021400Highwire
Jan 2022600Highwire
Feb 2022900Highwire
Mar 2022600Highwire
Apr 2022500Highwire
May 20221000Highwire
Jun 2022900Highwire
Jul 2022400Highwire
Aug 2022300Highwire
Sep 20221500Highwire
Oct 2022200Highwire
Nov 2022600Highwire
Dec 2022600Highwire
Jan 2023400Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me